Diasorin paying $1.8B to acquire multiplex diagnostic ...
https://www.bioworld.com/articles/505885-diasorin-paying-18b-to-acquire-multiplex-diagnostic-specialist-luminex
Apr 13, 2021 · Consolidation in diagnostics continues apace, with Diasorin SpA set to take over Luminex Corp. in an all-cash deal that values the multiplex diagnostics and molecular testing specialist at $1.8 billion. At $37 per share, the price is a 23% premium to the Luminex (NASDAQ:LMNX) share price on Feb. 23, which is when rumors of the acquisition began to circulate, and 12% above the close last …
DA: 83 PA: 58 MOZ Rank: 93